KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Buildings (2016 - 2025)

Gilead Sciences' Buildings history spans 16 years, with the latest figure at $4.6 billion for Q4 2025.

  • For Q4 2025, Buildings rose 1.83% year-over-year to $4.6 billion; the TTM value through Dec 2025 reached $4.6 billion, up 1.83%, while the annual FY2025 figure was $4.6 billion, 1.83% up from the prior year.
  • Buildings reached $4.6 billion in Q4 2025 per GILD's latest filing, up from $4.5 billion in the prior quarter.
  • In the past five years, Buildings ranged from a high of $4.6 billion in Q4 2025 to a low of $3.8 billion in Q4 2021.
  • Average Buildings over 5 years is $4.3 billion, with a median of $4.4 billion recorded in 2022.
  • Peak YoY movement for Buildings: rose 15.71% in 2022, then fell 1.41% in 2023.
  • A 5-year view of Buildings shows it stood at $3.8 billion in 2021, then increased by 15.71% to $4.4 billion in 2022, then fell by 1.41% to $4.3 billion in 2023, then rose by 4.88% to $4.5 billion in 2024, then rose by 1.83% to $4.6 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Buildings are $4.6 billion (Q4 2025), $4.5 billion (Q4 2024), and $4.3 billion (Q4 2023).